Quotables
"Transmission of documents via telephone wires is possible in principle, but the apparatus required is so expensive that it will never become a practical proposition."
Dennis Gabor, British physicist
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6703022 | Composition and method useful for treating colic The invention provides compositions and methods that are useful for treating colic in mammals (e.g. human infants).... | 03/09/2004 |
| 6664292 | Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor In accordance with the present invention, there are provided methods for treatment of pathological conditions of the nail, said method comprising topically applying to the affected area an effective amount of a composition comprising an optionally substit... | 12/16/2003 |
| 6632842 | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the prese... | 10/14/2003 |
| 6627632 | Compositions and methods for the treatment of anorectal disorders Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2-) scavengers, ଲ-adrenergic agonists, cAMP-dependent protein kinase activa... | 09/30/2003 |
| 6602906 | Method for delivering ascorbic acid and acetone to the dermal layer of the skin The present invention provides a more efficient method of delivering therapeutically effective amounts of ascorbic acid and acetone to the dermal layer of the skin via the topical application of 5,6-O-isopropylidene L-ascorbic acid. This invention further... | 08/05/2003 |
| 6596740 | Nicotine mucosal spray A composition for administration to the nasal mucosa of a subject comprises a solution of nicotine or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable solvent. The composition has a nicotine concentration less than 10 mg/ml. The... | 07/22/2003 |
| 6596306 | Drug delivery system:formulation for fat-soluble drugs This invention relates to a novel formulation for fat-soluble drugs which self-emulsify in the presence of an aqueous medium with little agitation. More specifically, the invention is concerned with the formulation of a new dosage form for fat-soluble dru... | 07/22/2003 |
| 6596754 | Preventives/remedies for multiple organ failure The present invention relates to a preventive and/or therapeutic drug for hypercytokinemia, liver diseases, and syndromes caused by the aggravation of sepsis, containing an anti-thrombin agent and/or a thrombin production inhibitor as an active ingredient... | 07/22/2003 |
| 6589982 | Use of prenylated flavones Flavones with an isoprenyl group in the 8-position possess very good anti-inflammatory properties and can also be used to treat/prevent/cure skin-disorders when applied in food compositions.... | 07/08/2003 |
| 6589535 | Nutritional supplement based on blackcurrent seed oil The present invention relates to the use of a composition comprising an oil with a high content of essential fatty acids of ω3 and ω6 type, preferably blackcurrant seed oil, and at least one compound selected from ଲ-carotene, lycopene, tocopherol ... | 07/08/2003 |
| 6589989 | Treatment of cell-mediated immune diseases The invention is related to a method of treating chronic hand eczema in a human patient in need of treatment, using oral administration of 9-cis retinoic acid and pharmaceutically acceptable salts and pharmaceutically acceptable hydrolysable esters thereo... | 07/08/2003 |
| 6586444 | Medicinal compositions To provide a pharmaceutical composition comprising a macrolide compound, such as tricyclic compound (I) or its pharmaceutically acceptable salt, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thic... | 07/01/2003 |
| 6579865 | Penetration enhancing and irritation reducing systems This invention lies in the technology of transdermal and topical drug delivery. In particular, the present invention relates to enhancement of the penetration of transdermally or topically applied drugs and with the reduction of skin irritation that often... | 06/17/2003 |
| 6573301 | Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use Topical compositions which include urea and carbamide peroxide are described. Compositions having a pH in the acidic range, particularly in the range of about 2.5 to about 9 are also described. Methods for treating dermatological disorders using the compo... | 06/03/2003 |
| 6566405 | Synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga Novel compositions of matter containing aromatic compounds and terpenoids which are present in and may preferably be derived from the plant Alpinia galanga (Zingiberaceae) show synergistic effects with respect to immunomodulation, and they significantly s... | 05/20/2003 |
| 6562377 | Composition to stop hairloss A composition to stop hair-loss and a method of making said composition with a base of paraffin oil, pure alcohol and fur of otters or minks. This composition is oily and is applied on the part of the head which suffers from hair falling. The remaining on... | 05/13/2003 |
| 6562855 | Anaesthetic formulation comprising an NMDA-antagoinst and an alpha-2 adrenergic agonist A pharmaceutical composition is described. The composition comprises a formulation. The formulation comprises an NMDA antagonist and an alpha-2 adrenergic agonist. In a preferred aspect, there is provided an improved anaesthetic comprising an NMDA antagon... | 05/13/2003 |
| 6562802 | Medical composition and uses thereof A composition is described, which comprises a cationic, hydrophilic, amine containing cationic derivatives of native chitosan; bound to an anionic scavenger substance, which is either (a) selected from the group consisting of anionic ethylene amine compou... | 05/13/2003 |
| 6562865 | Composition comprising a tramadol material and an anticonvulsant drug This invention relates to a pharmaceutical composition comprising a combination of a tramadol material and an anticonvulsant drug and to the pharmacological use of the composition in treating conditions of pain and neurologic or psychiatric disorders. The... | 05/13/2003 |
| 6544966 | Agents promoting laminin production in skin cells Disclosed are compositions for promoting the production of laminin 5 in epidermic cells which contain a lysophospholipid having a C14-22 fatty acid residue or a preparation derived from soybeans as an active ingredient and which can be used in ... | 04/08/2003 |
| 6541517 | Treatment of skin disorders The present invention provides a method and composition for treating skin disorders, skin pathologies and pruritus, which includes applying a compound of formula (I) in a suitable formulation to the affected area.... | 04/01/2003 |
| 6525073 | Prevention or treatment of insomnia with a neurokinin-1 receptor antagonist A tachykinin antagonist is useful, alone or in conjunction with other agents, for altering circadian rhythmicity and alleviating circadian rhythm disorders and for enhancing and improving the quality of sleep.... | 02/25/2003 |
| 6524602 | Polymer delivery system in treatments for parasitic skin diseases A formulation for the treatment of a parasitic skin disease includes a parasiticide to kill the parasite. The formulation also includes a polymer effective to increase retention of the formulation on the skin, and to reduce absorption of the formulation i... | 02/25/2003 |
| 6518308 | Compositions for adhesion prevention Compositions and methods for the prevention of adhesion development involve the administration of therapeutic formulations of a halogenated organic compound to a patient in need of treatment. The formulations can include suitable carriers for optimal admi... | 02/11/2003 |
| 6509375 | Method for increasing productivity in breeder hens A method for increasing chick production by increasing the level of L-DOPA in the bloodstream of breeder hens is described. Chick production is increased by increasing rates of egg laying, fertility of laid eggs, and number of fertile eggs that hatch. Met... | 01/21/2003 |
| 6506753 | Methods of making and using N-desmethylzopiclone The invention is directed to compositions comprising, and methods of using, racemic N-desmethylzopiclone, optically pure (+)-N-desmethylzopiclone, and optically pure (-)-N-desmethylzopiclone in the treatment and prevention of diseases and conditions in ma... | 01/14/2003 |
| 6503953 | Methods for treating atopic disorders A method for treating an atopic disorder in a patient is provided. The method comprises administering to the patient an effective amount of at least one of an antifungal and an antibiotic over a period of time. The method further comprises reducing over t... | 01/07/2003 |
| 6500460 | Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities This invention relates to formulations for the prevention of infection and/or abnormal conditions of mucosae and/or skin caused by any pathogen and/or any disease, and more particularly for the prevention of sexually transmitted infections specially HIV a... | 12/31/2002 |
| 6500843 | Inhibitors of rotamase enzyme activity This invention relates to the method of using neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptid... | 12/31/2002 |
| 6497904 | Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent Novel pharmaceutical formulations for treating a cellular proliferative disease are provided comprising: a therapeutically effective amount of a Golgi apparatus disturbing agent; a biocompatible carrier; and a solvent. In preferred formulations, the Golgi... | 12/24/2002 |
| 6495531 | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain The present invention relates to the new use of glucosamine and/or its derivatives for the preparation of a therapeutical composition for treating and quick relief of itching and/or local pain which results from a variety of causes. The invention further ... | 12/17/2002 |
| 6492395 | Topical formulation of alkyl-, phenyl-pyridone A pharmaceutically acceptable topical formulation for the treatment and/or prevention of skin ailments, more particularly of fibriotic nature such as fibriotic lesional tissues, contiguous warts, contact dermatitis, and keloids, and to assist the healing ... | 12/10/2002 |
| 6489308 | Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions A novel method of treating and preventing diseases is provided. In particular, compositions and methods of blocking diseases associated with aberrant levels of nitric oxide and facilitated by a serine proteolytic (SP) activity are disclosed, which consist... | 12/03/2002 |
| 6486152 | Topical carbamazepine formulations and methods of use A therapeutic formulation comprises a topically acceptable semisolid vehicle and carbamazepine, the vehicle consisting of components that are compatible with the carbamazepine, and the carbamazepine being in a concentration sufficient to permit a therapeu... | 11/26/2002 |
| 6476008 | Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder The invention relates to use of diphosphonic acids or physiologically compatible salts or esters thereof for preventive treatment of disturbances to ossary mineralization which may occur after operative extension of the urine bladder by augmentation plast... | 11/05/2002 |
| 6476014 | Chelated 8-hydroxyquinoline for the treatment of epithelial lesions Oxinates including 8-hydroxyquinoline and a heavy metal are topically applied to epidermal lesions for therapeutic effect, wherein said epithelial lesions selected from the croup consisting of cancerous lesions, precancerous lesions, cysts and warts; and ... | 11/05/2002 |
| 6469070 | Topical medicament comprising phenolic biocide and choline A topical medicament for the treatment of warts, corns and verrucae including a phenolic biocide, which is preferably a compound of formula (I), in which n is from 0 to 19, in combination with choline or a derivative or a salt thereof. A method for treatm... | 10/22/2002 |
| 6469069 | Propofol composition containing sulfite Sterile pharmaceutical compositions for parenteral administration containing 2,6-diisopropylphenol (propofol) are described for use as anesthetics. The compositions comprise an oil-in-water emulsion of propofol additionally comprising an amount of sulfite... | 10/22/2002 |
| 6465510 | Emulsion containing ascorbic acid and its uses in the cosmetics and dermatological fields A water-in-oil emulsion containing ascorbic acid and, as an emulsifier, a dimethiconecopolyol or an alkyldimethiconecopolyol, where the aqueous phase having a pH ranging from 5.5 to 7.5. This emulsion allows ascorbic acid to be stabilized and can be used,... | 10/15/2002 |
| 6465442 | Topical application of muscarinic and opioid agents for treatment of tinnitus The present invention relates to a compositions and methods for treating tinnitus. In preferred embodiments of the invention, muscurinic and/or opioid agents are administered to the affected ear in amount effective to relieve one or more tinnitus symptoms... | 10/15/2002 |
